Sara Cuadrado-Castano

8PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGenetically modified animalsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 28, 2026
In situ APMV-4 vaccination primes systemic response to subtherapeutic dosing of aCTLA-4 in colorectal carcinoma.

|Nov 05, 2025
Infectious bursal disease virus (IBDV) as a novel oncolytic virotherapy in glioblastoma.

Vicent Tur-Planells, Yonina Bykov, Gloria Dawodu

|Sep 15, 2025
Lymphangiogenesis driven by VEGF-C reshapes tumor immune landscape and enables tumor eradication by viral immunotherapy.

Ruben Fernandez-Rodriguez, Sara Cuadrado-Castano, Andrew Edwards

|Nov 23, 2024
Outcome of SARS-CoV-2 reinfection depends on genetic background in female mice.

Gagandeep Singh, Juan García-Bernalt Diego, Prajakta Warang

|Dec 11, 2023
Host immune responses associated with SARS-CoV-2 Omicron infection result in protection or pathology during reinfection depending on mouse genetic background.

Gagandeep Singh, Prajakta Warang, Juan García-Bernalt Diego

|Oct 28, 2023
Engineering Non-Human RNA Viruses for Cancer Therapy.

Vicent Tur-Planells, Adolfo García-Sastre, Sara Cuadrado-Castano

Pageof 2

Frequent Collaborators

6 joint publications

Adolfo García-Sastre

2 joint publications

Lars Pache

2 joint publications

Lauren Chang

2 joint publications

Michael Schotsaert